Genflow CEO talks through dog study and why partnerships
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) this week reaffirmed its focus on capital efficiency and pipeline advancement following a €4...…
0,023€
21,05%
Echtzeit-Aktienkurs Genflow Biosciences PLC
Bid:
Ask:
Nachrichten zur Genflow Biosciences PLC Aktie
Genflow Biosciences confirms priorities as it confirms progress in €4m funding
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) told investors it has received administrative approval for previously announced funding support of...…
Genflow shares jump as biotech appoints new chairman
Shares in Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) rose 13% to 2.08p after the company named a new chairman, a move…
Genflow names new chairman as gene therapy group looks to next phase
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has appointed a new chairman as the London-listed biotechnology company steps up efforts to push...…
Genflow is ready for “a year of catalysts”
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) this week outlined a series of near- and medium-term catalysts as the company enters what…
Genflow is ready for “a year of catalysts”
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) this week outlined a series of near- and medium-term catalysts as the company enters what…
Gene therapy biotech Genflow eyes busy year ahead as dog ageing trial nears results
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) has wrapped up 2025 with steady progress across a range of gene therapy programmes, including…
Genflow eyes busy year ahead as dog ageing trial nears results
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) has wrapped up 2025 with steady progress across a range of gene therapy programmes, including…
Genflow Biosciences completes dosing in canine gene therapy
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) told investors it has completed the dosing phase of its canine gene therapy trial. All enrolled dogs...…
Genflow Biosciences secures EU patent for Sirtuin-6 tech
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the companys recent milestone – the granting…
Genflow expands IP portfolio protection
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) told investors it has filed a patent examination request in China for its SIRT6 gene variants…
Genflow surges as dog ageing trial hits safety milestone
Shares in Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) jumped 19% on Friday, extending a remarkable 169% gain over the week, after…
Genflow hits safety milestone in ageing therapy for dogs
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), the London-listed longevity company, has reached a key milestone in its effort to see whether…
Genflow shares surge 88% after new funding deal deemed less dilutive
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) shares jumped 88% on Thursday after the longevity-focused biotech firm announced a £440,000 fundraising that...…
Genflow raises £340,000 through share issue backed by US investor
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), the longevity-focused biotech group, has secured £340,000 in fresh funding through the issue of 40…
Genflow eyes pivotal year as ageing therapies advance
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has said it expects 2026 to be a decisive year as it pushes forward its…
Genflow Biosciences signs deals with animal health firms
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s recently signed confidential disclosure...…
Genflow seeks China patent protection for liver disease therapy
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has moved to strengthen its intellectual property in Asia by filing for examination of a…
Genflow Biosciences advances lead longevity programmes
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has reported progress across its two main research programmes, as the company moves closer to…
Genflow reaffirms €4m Wallonia grant as GF-1002 programme on track
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) confirmed that it has been awarded roughly €4 million in non-dilutive financial support from the Wallonia...…
Genflow advances gene therapy pipeline with new partnerships and patent progress
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has made headway across its gene therapy pipeline, reporting strong mid-year momentum in its programmes...…
Genflow formalises research deal with Belgian biotech partner CER
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has signed a long-term agreement with its Belgian research partner CER Groupe to support the…
Genflow moves closer to Japanese patent for healthy ageing gene variant
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has taken a step forward in its bid to protect a key gene therapy technology…
Genflow Biosciences raises new capital as dog gene trial advances
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has topped up its coffers with a £500,000 share subscription to support its proof-of-concept trial.…
Genflow Biosciences moves forward on MASH trial
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) outlined recent developments across its pipeline following the release of its 2024 results. The company…
Genflow Biosciences highlights progress in key research
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) reported progress across its research programmes and raised new funds during the 2024 financial year.…
AI boosts Genflow’s drug research capabilities
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s new strategic partnership with US-based…
AI boosts Genflow’s drug research capabilities
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s new strategic partnership with US-based…